Nephros, Inc.
NEPH
$2.00
-$0.0059-0.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 153.36% | 200.55% | 33.26% | 44.77% | 28.76% |
| Total Depreciation and Amortization | -31.37% | -41.07% | -33.96% | -37.04% | -7.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.09% | -38.65% | -87.70% | -62.58% | 268.67% |
| Change in Net Operating Assets | 167.03% | -278.86% | -154.13% | -2,432.26% | -231.74% |
| Cash from Operations | 650.21% | -210.85% | -321.68% | -343.48% | -21.54% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 66.67% | -- | 0.00% | 97.30% | 96.25% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 66.67% | -- | 0.00% | 97.30% | 97.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 513.65% | -210.85% | -346.88% | -433.66% | -2.94% |